SUBSTANCE-P SECRETION BY CARCINOID TUMORS

被引:49
作者
SKRABANEK, P
CANNON, D
KIRRANE, J
POWELL, D
机构
[1] Endocrine Unit, Mater Misericordiae Hospital, Dublin
关键词
D O I
10.1007/BF02939369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In 3 patients with foregut and midgut carcinoid tumours, high levels of immunoreactive substance P (ISP) were demonstrated in the general circulation, in the tumour extracts, in the tumour tissue culture medium, and in venous effluents from tumour and from metastases. In one patient studied during an attack of the carcinoid syndrome, ISP level was higher than in the basal state. Since substance P (SP) can cause flushing, hypotension, tachycardia, increased intestinal motility, and broncho-constriction, it may contribute to the pathophysiology of the carcinoid syndrome. Plasma ISP may serve as a circulating tumour marked and the levels may be used to monitor the response to therapy. © 1978 Springer-Verlag.
引用
收藏
页码:47 / 49
页数:3
相关论文
共 25 条
[1]   SUBSTANCE-P AND 5-HT IN GRANULES ISOLATED FROM AN INTESTINAL ARGENTAFFIN CARCINOID [J].
ALUMETS, J ;
HAKANSON, R ;
INGEMANSSON, S ;
SUNDLER, F .
HISTOCHEMISTRY, 1977, 52 (03) :217-222
[2]   THE DISTRIBUTION OF SUBSTANCE-P AND 5-HYDROXYTRYPTAMINE IN THE CENTRAL NERVOUS SYSTEM OF THE DOG [J].
AMIN, AH ;
CRAWFORD, TBB ;
GADDUM, JH .
JOURNAL OF PHYSIOLOGY-LONDON, 1954, 126 (03) :596-618
[3]   ACTIONS OF SOME PEPTIDES ON BRONCHIAL MUSCLE [J].
BHOOLA, KD ;
SHORLEY, PG ;
SCHACHTER, M ;
COLLIER, HOJ .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1962, 19 (01) :190-&
[4]  
BISSET GW, 1962, BRIT J PHARM CHEMOTH, V19, P168
[5]  
CHANG MM, 1970, J BIOL CHEM, V245, P4784
[6]   FRACTIONATION OF THE SMOOTH MUSCLE STIMULANTS PRESENT IN EXTRACTS OF GASTRO-INTESTINAL TRACT - IDENTIFICATION OF 5-HYDROXYTRYPTAMINE AND ITS DISTINCTION FROM SUBSTANCE-P [J].
DALGLIESH, CE ;
TOH, CC ;
WORK, TS .
JOURNAL OF PHYSIOLOGY-LONDON, 1953, 120 (03) :298-310
[7]   CIRCULATORY STUDIES ON SUBSTANCE-P IN MAN [J].
DUNER, H ;
PERNOW, B .
ACTA PHYSIOLOGICA SCANDINAVICA, 1960, 49 (2-3) :261-266
[8]  
ERSPAMER V, 1954, PHARMACOL REV, V6, P425
[9]  
Erspamer V., 1973, PURE APPL CHEM, V35, P463, DOI [10.1351/pac197335040463, DOI 10.1351/PAC197335040463]
[10]  
GRAHAMESMITH DG, 1972, CARCINOID SYNDROME, P43